120 related articles for article (PubMed ID: 29145000)
1. Proopiomelanocortin processing and prohormone convertase 1 level in dogs with pituitary corticotroph tumors.
Benchekroun G; de Fornel-Thibaud P; Rosenberg D
Domest Anim Endocrinol; 2018 Jan; 62():83-87. PubMed ID: 29145000
[TBL] [Abstract][Full Text] [Related]
2. Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma.
Tateno T; Izumiyama H; Doi M; Akashi T; Ohno K; Hirata Y
Endocr J; 2007 Dec; 54(5):777-82. PubMed ID: 17917309
[TBL] [Abstract][Full Text] [Related]
3. Post-translational processing of proopiomelanocortin (POMC) in mouse pituitary melanotroph tumors induced by a POMC-simian virus 40 large T antigen transgene.
Low MJ; Liu B; Hammer GD; Rubinstein M; Allen RG
J Biol Chem; 1993 Nov; 268(33):24967-75. PubMed ID: 8227058
[TBL] [Abstract][Full Text] [Related]
4. Processing of high-molecular-weight form adrenocorticotropin in human adrenocorticotropin-secreting tumor cell line (DMS-79) after transfection of prohormone convertase 1/3 gene.
Tateno T; Kato M; Tani Y; Yoshimoto T; Oki Y; Hirata Y
J Endocrinol Invest; 2010 Feb; 33(2):113-7. PubMed ID: 19786827
[TBL] [Abstract][Full Text] [Related]
5. Plasma pro-opiomelanocortin, pro-adrenocorticotropin hormone, and pituitary adenoma size in dogs with Cushing's disease.
Granger N; de Fornel P; Devauchelle P; Segond S; Delisle F; Rosenberg D
J Vet Intern Med; 2005; 19(1):23-8. PubMed ID: 15715043
[TBL] [Abstract][Full Text] [Related]
6. Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I--immunohistochemical study.
Ohta S; Nishizawa S; Oki Y; Yokoyama T; Namba H
Pituitary; 2002; 5(4):221-3. PubMed ID: 14558669
[TBL] [Abstract][Full Text] [Related]
7. Profiles of pro-opiomelanocortin and encoded peptides, and their processing enzymes in equine pituitary pars intermedia dysfunction.
Carmalt JL; Mortazavi S; McOnie RC; Allen AL; Unniappan S
PLoS One; 2018; 13(1):e0190796. PubMed ID: 29309431
[TBL] [Abstract][Full Text] [Related]
8. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
9. Why don't corticotroph tumors always produce Cushing's disease?
García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A
Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease.
Iino K; Oki Y; Matsushita F; Yamashita M; Hayashi C; Miura K; Nishizawa S; Nakamura H
Pituitary; 2007; 10(1):35-45. PubMed ID: 17410413
[TBL] [Abstract][Full Text] [Related]
11. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
[TBL] [Abstract][Full Text] [Related]
12. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
Bertagna X
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
[TBL] [Abstract][Full Text] [Related]
13. PC1/3 and PC2 gene expression and post-translational endoproteolytic pro-opiomelanocortin processing is regulated by photoperiod in the seasonal Siberian hamster (Phodopus sungorus).
Helwig M; Khorooshi RM; Tups A; Barrett P; Archer ZA; Exner C; Rozman J; Braulke LJ; Mercer JG; Klingenspor M
J Neuroendocrinol; 2006 Jun; 18(6):413-25. PubMed ID: 16684131
[TBL] [Abstract][Full Text] [Related]
14. Expression of proopiomelanocortin and prohormone convertase-1 and -2 in the late gestation fetal sheep pituitary.
Bell ME; Myers TR; Myers DA
Endocrinology; 1998 Dec; 139(12):5135-43. PubMed ID: 9832453
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
16. Impaired processing of proopiomelanocortin in corticotroph macroadenomas.
Gibson S; Ray DW; Crosby SR; Dornan TL; Jennings AM; Bevan JS; Davis JR; White A
J Clin Endocrinol Metab; 1996 Feb; 81(2):497-502. PubMed ID: 8636257
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.
Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y
Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378
[TBL] [Abstract][Full Text] [Related]
19. In vitro processing of proopiomelanocortin by recombinant PC1 (SPC3).
Friedman TC; Loh YP; Birch NP
Endocrinology; 1994 Sep; 135(3):854-62. PubMed ID: 8070378
[TBL] [Abstract][Full Text] [Related]
20. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]